Discovery, Translation, and the State of Bio ...

Julie Yoo sits down with Dr. Suchi Saria, founder and CEO of Bayesian Health, to discuss the current state of clinical AI and what it takes to deploy AI systems in real-world healthcare settings. While much of the recent attention around AI has focused on copilots, chatbots, and ...  Show more

Nicolás Abad, founder and CEO of Telepatía, joins a16z to discuss building AI-powered tools for healthcare in Latin America. Inspired by the loss of his father to a preventable medical error, Adbad set out to address one of the region’s most significant challenges: a shortage of ...  Show more

Can we make science as fast as software? 

In this episode, Erik Torenberg talks with Patrick Hsu (cofounder of Arc Institute) and a16z general partner Jorge Conde about Arc’s “virtual cells” moonshot, which uses foundation models to simulate biology and guide experiments ...

The latest innovations in biotech are upending our approach to disease, longevity and climate change. Are we ready? This hour, TED speakers share ideas at the forefront of this new wave. Guests include co-founder of the Human Cell Atlas Aviv Regev, physical chemist Brad Ringeisen ...  Show more

We look at a gene editing breakthrough, a new technique to correct genetic errors in sick patients. Roland speaks to Professor David Liu to learn about the base editing technology.Also, we look into the complex causes of last year's post-pandemic spike in child hepatitis. Profess ...  Show more

Fareed examines two emerging technologies that are already changing life as we know it—CRISPR gene editing and artificial intelligence—in interviews with two women who pioneered them: UC Berkeley’s Jennifer Doudna and Stanford’s Fei-Fei Li. Learn more about your ad choices. Visit ...  Show more